Mapping Neurodegeneration with Spatial Glycoproteomics
Combined proteomic and glycomic profiling reveals molecular signatures of Alzheimer’s and Lewy body disease
False
Combined proteomic and glycomic profiling reveals molecular signatures of Alzheimer’s and Lewy body disease
A spatial mass spectrometry workflow was developed to analyze brain proteins and sugars on microscope slides.
The method enhances molecular coverage, allowing deeper analysis of glycosylated proteins linked to neurodegeneration.
The study identified over 4,000 proteins, revealing significant molecular differences associated with aging and neurodegenerative diseases.
Altered extracellular matrix proteins and reduced chondroitin sulfate glycans were linked to Alzheimer’s disease with Lewy body pathology.
The researchers aim to support biomarker discovery and improve diagnosis and treatments through this high-resolution profiling technique.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

False
False
April 3, 2025
13 min read
Computers can “see” and “hear,” but fully digitizing scent has so far eluded science – but that may soon change
December 3, 2024
3 min read
Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer
December 5, 2024
6 min read
Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards
Affiliations:
Specialties:
Areas of Expertise:
False